News Detail

Kolkata, 27 Oct 2023: Low back pain (LBP) is a global health concern. Management of LBP aims at pain relief facilitating improvement of functional ability. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first line of therapy. However, the selection of NSAIDs is challengin......
View Details
Source : Cureus
fixed-dose combination (fdc)
thiocolchicoside
randomized controlled trial (rct)
low back pain (lbp)
etoricoxib
Related News
- New method identifies bacteria more easily (03-12-2023)
- Spanish scientists discover a promising therapeutic target for cardiac arrhythmias (03-12-2023)
- Researchers develop one-dollar cancer treatment using engineered bacteria (01-12-2023)
- Protected droplets as a new transport route for medicines (01-12-2023)
- An Oral Probiotic Can Treat Dry Eye Disease: Study (30-11-2023)
- Researchers develop faster, cheaper, and more precise method for identifying bacteria (30-11-2023)
- Over 900 known and novel genes responsible for AMR revealed in a study (29-11-2023)
- New device could replace animals used in drug safety testing (29-11-2023)
- Decades of mRNA Research Come to Fruition (28-11-2023)
- AI to detect antibiotic resistance faster than gold-standard testing (28-11-2023)